Upexi, Inc. (NASDAQ:UPXI - Get Free Report)'s stock price was up 14.2% during mid-day trading on Friday . The stock traded as high as $6.28 and last traded at $6.36. Approximately 3,543,281 shares changed hands during trading, an increase of 10% from the average daily volume of 3,233,449 shares. The stock had previously closed at $5.57.
Analysts Set New Price Targets
Several research analysts recently issued reports on UPXI shares. Wall Street Zen raised Upexi to a "hold" rating in a research report on Friday, May 30th. Alliance Global Partners assumed coverage on Upexi in a research report on Monday, August 4th. They set a "buy" rating and a $15.00 target price on the stock. Finally, Cantor Fitzgerald raised Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 price objective on the stock in a report on Monday, June 16th.
Get Our Latest Stock Analysis on UPXI
Upexi Trading Up 8.4%
The business has a fifty day moving average price of $6.95 and a two-hundred day moving average price of $6.06. The company has a quick ratio of 0.24, a current ratio of 0.37 and a debt-to-equity ratio of 0.31.
Upexi (NASDAQ:UPXI - Get Free Report) last announced its quarterly earnings data on Friday, May 16th. The company reported ($2.87) earnings per share for the quarter. The firm had revenue of $3.16 million during the quarter. Upexi had a negative net margin of 135.86% and a negative return on equity of 535.19%.
Insider Buying and Selling
In related news, CEO Allan Marshall bought 161,943 shares of the company's stock in a transaction that occurred on Friday, July 11th. The shares were purchased at an average cost of $4.94 per share, with a total value of $799,998.42. Following the completion of the acquisition, the chief executive officer directly owned 1,046,261 shares in the company, valued at approximately $5,168,529.34. The trade was a 18.31% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Lawrence Dugan bought 4,000 shares of the company's stock in a transaction that occurred on Tuesday, July 22nd. The shares were bought at an average cost of $7.50 per share, for a total transaction of $30,000.00. Following the completion of the acquisition, the director owned 116,389 shares of the company's stock, valued at $872,917.50. This trade represents a 3.56% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 198,186 shares of company stock valued at $997,759 over the last ninety days. Company insiders own 31.60% of the company's stock.
Institutional Trading of Upexi
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of Montreal Can purchased a new position in Upexi during the fourth quarter worth approximately $36,000. North Star Investment Management Corp. purchased a new position in Upexi during the second quarter worth approximately $45,000. Geode Capital Management LLC purchased a new position in Upexi during the second quarter worth approximately $1,002,000. Finally, Kathmere Capital Management LLC purchased a new position in Upexi during the second quarter worth approximately $6,535,000. 5.68% of the stock is owned by institutional investors and hedge funds.
Upexi Company Profile
(
Get Free Report)
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
See Also
Before you consider Upexi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upexi wasn't on the list.
While Upexi currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
